Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Internal medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.50.5101PMID 21841326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease.

  2011influential reference
• Brain magnetic resonance imaging (MRI) in parkinsonian disorders.

  2009cited by this paper
• MRI characteristics of the substantia nigra in Parkinson's disease: A combined quantitative T1 and DTI study

  2009cited by this paper
• Monoamine neurons in the human brain stem: anatomy, magnetic resonance imaging findings, and clinical implications

  2008cited by this paper
• Midbrain iron content in early Parkinson disease

  2008cited by this paper
• Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease

  2006influential reference
• Progression of putaminal degeneration in multiple system atrophy: A serial diffusion MR study

  2006cited by this paper
• The role of radiotracer imaging in Parkinson disease.

  2005cited by this paper
• Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

  2005cited by this paper
• Cerebrovascular perfusion in marijuana users during a month of monitored abstinence

  2004cited by this paper
• The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.

  2004cited by this paper
• Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration.

  2004influential reference
• Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease

  2004cited by this paper
• Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia

  2003cited by this paper
• Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy

  2003cited by this paper
• Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD

  2002cited by this paper
• Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour

  2001cited by this paper
• Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence.

  2000cited by this paper
• Progressive supranuclear palsy (Steele-Richardson-Olszewski disease)

  1999cited by this paper
• [Cortical lesions in progressive supranuclear palsy (Steele-Richardson-Olszewski disease)].

  1999influential reference
• Consensus statement on the diagnosis of multiple system atrophy

  1998cited by this paper
• Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology.

  1998cited by this paper
• Innervation of propatagial musculature in a flying squirrel, Glaucomys volans (Rodentia, Sciuridae).

  1996cited by this paper
• Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• Innervation of propatagial musculature in a flying squirrel, Glaucomys volans (Rodentia, Sciuridae).

  1996cited by this paper
• Increased iron‐related MRI contrast in the substantia nigra in Parkinson's disease

  1995cited by this paper
• T2 relaxation time in patients with Parkinson's disease

  1993cited by this paper
• Ageing and Parkinson's disease: substantia nigra regional selectivity.

  1991cited by this paper
• THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE

  1989cited by this paper
• Increased Nigral Iron Content and Alterations in Other Metal Ions Occurring in Brain in Parkinson's Disease

  1989cited by this paper

• Substantia nigra degeneration in spinocerebellar ataxia 2 and 7 using neuromelanin‐sensitive imaging

  2025cites this paper
• Beyond Parkinson's Disease: A Narrative Review of Neuromelanin MRI in Neurodegenerative Diseases

  2025cites this paper
• Multimodal MRI biomarkers optimize differentiation between progressive supranuclear palsy and Parkinson's disease.

  2025cites this paper
• Locus coeruleus degeneration is associated with orthostatic hypotension in Parkinson's disease and multiple system atrophy.

  2025cites this paper
• Brainstem and cerebellar radiological findings in progressive supranuclear palsy

  2025cites this paper
• Regional nigral neuromelanin degeneration in asymptomatic leucine-rich repeat kinase 2 gene carrier using MRI

  2024cites this paper
• Neuromelanin‐sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson's disease

  2024cites this paper
• Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions

  2024cites this paper
• Improved diagnostic performance of susceptibility-weighted imaging with compressed sensing-sensitivity encoding and neuromelanin-sensitive MRI for Parkinson's disease and atypical Parkinsonism.

  2023cites this paper
• The role of magnetic resonance imaging in the diff erential diagnosis of Parkinson’s disease

  2023cites this paper
• Visual fixation suppression of caloric nystagmus in progressive supranuclear palsy – A comparison with Parkinson’s disease

  2023cites this paper
• Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function.

  2023cites this paper
• Quantitative MRI protocol and decision model for a ‘one stop shop’ early-stage Parkinsonism diagnosis: Study design

  2023cites this paper
• Regional Selectivity of Neuromelanin Changes in the Substantia Nigra in Atypical Parkinsonism

  2022cites this paper
• Depression in multiple system atrophy: Views on pathological, clinical and imaging aspects

  2022cites this paper
• 파킨슨병의 자기공명영상 소견: 흑질선조체 변성의 영상학적 평가

  2022cites this paper
• MRI Signs of Parkinson’s Disease and Atypical Parkinsonism Magnetresonanztomografische Zeichen des idiopathischen Parkinson-Syndroms sowie atypischer Parkinson-Syndrome

  2021cites this paper
• Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging.

  2021cites this paper
• MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.

  2020cites this paper
• A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy

  2020influential citation
• The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism

  2020influential citation
• The utility of the combined use of 123I-FP-CIT SPECT and neuromelanin MRI in differentiating Parkinson's disease from other parkinsonian syndromes

  2019cites this paper
• Neuroimaging in Vascular Parkinsonism

  2019cites this paper
• Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear Palsy

  2019cites this paper
• New MRI diagnostic methods in Parkinson's disease: evaluating nigral degeneration

  2019cites this paper
• Life span pigmentation changes of the substantia nigra detected by neuromelanin‐sensitive MRI

  2018cites this paper
• Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease

  2018cites this paper
• Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease

  2018cites this paper
• Recent Advances in Biomarkers for Parkinson’s Disease

  2018cites this paper
• Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism

  2018influential citation
• Structural Imaging in Atypical Parkinsonism.

  2018cites this paper
• Imaging Parkinsonian Pathology in Substantia Nigra with MRI

  2018cites this paper
• Magnetic resonance imaging for the diagnosis of Parkinson’s disease

  2017influential citation
• Pool size ratio of the substantia nigra in Parkinson’s disease derived from two different quantitative magnetization transfer approaches

  2017cites this paper
• Neuromelanin in parkinsonian disorders: an update

  2017cites this paper
• Correlation between neuromelanin-sensitive MR imaging and 123I-FP-CIT SPECT in patients with parkinsonism

  2016cites this paper
• Neuromelanin MR imaging in Parkinson ’ s disease

  2016cites this paper
• A longitudinal study of neuromelanin-sensitive magnetic resonance imaging in Parkinson's disease.

  2016cites this paper
• A Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin Imaging

  2016cites this paper
• A multicontrast approach for comprehensive imaging of substantia nigra

  2015cites this paper
• Neuromelanin-sensitive magnetic resonance imaging: a promising technique for depicting tissue characteristics containing neuromelanin

  2014cites this paper
• Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat.

  2014cites this paper
• Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach.

  2014cites this paper
• Neuromelanin Imaging in Parkinson Disease

  2013cites this paper
• Neuromelanin Magnetic Resonance Imaging in Parkinson's Disease and Multiple System Atrophy

  2013cites this paper
• Correlation between pathology and neuromelanin MR imaging in Parkinson’s disease and dementia with Lewy bodies

  2013cites this paper
• Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy , progressive supranuclear palsy , and Parkinson ' s disease : evaluation by 3 . 0-Tesla MR imaging

  2013cites this paper
• EFFECTS OF A UNILATERAL INTRASTRIATAL 6-HYDROXYDOPAMINE MODEL OF EARLY PARKINSON'S DISEASE ON MIDBRAIN DOPAMINE NEURONS IN RATS: A STEREOLOGICAL STUDY

  2013cites this paper
• Recent advances in structural MRI in Parkinson’s disease and atypical parkinsonian syndromes

  2012cites this paper
• Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging

  2012cites this paper